Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Yun Zhou

Yun Zhou

Johns Hopkins University School of Medicine USA

Elizabeth A Boerger

Elizabeth A Boerger

Slippery Rock University USA

Theodore A Petti

Theodore A Petti

Rutgers-Robert Wood Johnson Medical School USA

Ahmed Ammar

Ahmed Ammar

Dammam University Saudi Arabia

Alan M. Palmer

Alan M. Palmer

Cerebroscience Ltd UK

Alberto E. Musto

Alberto E. Musto

Eastern Virginia Medical School USA

Alessandro Morelli

Alessandro Morelli

Genova University Italy

Alex Bekker

Alex Bekker

Rutgers New Jersey Medical School USA

Dementia 2021

About Dementia 2021

Dementia Conferences 2021Alzheimers Conferences | Neurology Conferences | Dementia Congress

After successful completion of Dementia 2020, ConferenceSeries proudly invites all the participants and sponsors across the globe to participate in the “15th International Conference on Alzheimer Diseases and Dementia” (Dementia 2021) which will be held during September 27-28, 2021, Dublin, Ireland.

The principle subject of our meeting is "Advancements and Covid_19 challanges in Dementia" that covers intensive form of essentially important sessions. This meeting flow regarding enhancements within the field of insanity and about the new treatment techniques that square measure contrived by researchers to treat completely different maladies in less hard-to-please approach. This meeting goes concerning as a best stage for participants to search out concerning this pattern in insanity innovative work.

Dementia gathering can target the foremost recent and energizing developments in each facet of insanity think about that offers a noteworthy open door for agents over the world to fulfill, organize, and see new logical advancements. The 2 days gathering incorporates symposiums and exceptional keynote sessions semiconductor diode by notable and eminent speakers WHO exceed expectations within the field of insanity This Worldwide insanity Meeting likewise energizes the dynamic support of young understudies, forthcoming specialists and growing researchers as we have a tendency to square measure facilitating Poster Award Competition and Young analysis Forum at the gathering setting.

Why to attend?

According to United Nations agency 47.5 million folks have dementedness and each year 7.7 million new cases square measure showing. By 2030 total cases of dementia is projected to be 75.6 million and virtually triple by 2050 to one hundred thirty-five.5 million. Alzheimer’s sickness contributes 60-70 you look after cases in dementia and second commonest condition of dementedness is tube-shaped structure dementia that contributes 2 hundredth of cases everywhere the globe. Total calculable price of dementedness is 818 billion U.S.A. $ in 2015.

A great chance to network together with your peers from academe and business. At the dementia conferences and from the eminent folk’s speech, you'll update your data concerning current of dementia analysis and receive name recognition at this 2-day event. World-renowned speakers, the foremost recent techniques, tactics, and the newest updates in dementia field’s square measure hallmarks of this conference.

Significance and scope?

Nearly 90% of the world’s population, suffer from Neurological disorders, from Alzheimer and Parkinson disease, strokes, multiple sclerosis and epilepsy to migraine, brain injuries and neuroinfections, with some 6.8 million dying each year.

Highlights:

  • Dementia
  • Dementia Lewy Body
  • Care Practice and Awareness
  • Ageing and Dementia
  • Dementia Nursing
  • Recent Studies & Case Reports
  • Alzheimer’s Disease
  • Alzheimer’s Clinical Trials and Studies
  • Novel Therapeutic Targets and Mechanisms for Treatment
  • Amyloid Protein in Alzheimer’s and Dementia
  • Molecular Genetics and Biology of Dementia
  • Neurodegenerative Diseases
  • Psychiatry Mental health disorders
  • Animal Models and Translational Medicine
  • Vascular Dementia
  • Frontotemporal dementia
  • Parkinson Disease
  • Neurology and Neurosurgery
  • Neuropharmacology
  • Neuroimaging Biomarkers
  • Neuro Oncology and CNS
  • Recent Advancement in Treating Dementia

Target Audience:

  • Neurologists and Executives
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Health mind experts
  • Professors
  • Industrial Specialists
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Researchers
  • Lecturers and Understudies from the scholarly world in the investigation of Dementia
  • Students from the scholarly community in the examination of Neurology

Attending Benefits:

  • Meet Experts from World wide
  • Face to face interaction
  • Networking Opportunities
  • Expand your ideas
  • New Tips & Tactics
  • Grow your professional network

Who should sponsor/exhibit:

  • Pharmaceuticals
  • Drug Manufacturers
  • Hospitals
  • Educational Institutes
  • Research Centres
  • Associations
  • Societies
  • Dementia Care Centres

Sessions/Tracks

Track 1: Dementia

Dementia is that the term accustomed describe the symptoms of many conditions that touching the brain. The normally seen condition is Alzheimer’s, and alternative includes brain disease. Symptoms seen at early stages square measure temperament changes, withdrawal, state of mind, confusion and apathy. Early diagnosing helps with providing early treatment, support and designing. Medications would possibly facilitate with some symptoms of insanity, however no permanent cure.

Majority of individuals with insanity square measure higher than age sixty-five, the condition isn't traditional for all older people. The prevalence of insanity gets high with age, however it’s not if an older person can develop it. whereas solely 1-in-4 people with Alzheimer’s sickness or insanity has been diagnosed. Few additional things we'd like to grasp regarding tube insanity, insanity with lewy bodies, Fronto-temporal insanity, Rarer causes of insanity, brain disorder, HIV-related psychological feature impairment, delicate psychological feature impairment.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Recommended Conferences

Alzheimer's Association International Conference Denver, USA and Online July 26-30, 2021 | 12th International Conference on Dementia and Alzheimers Disease September 3-4, 2021 Paris, France | 2nd Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia Sep 06-08, 2021 London, UK | 2nd International Conference on Dementia March 25-26, 2022 Dubai, UAE

Track 2: Dementia Lewy Body

After Alzheimer's disease it is the second most common type of progressive dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement. Lewy body dementia causes a progressive decline in mental abilities. People with Lewy body dementia may experience visual hallucinations and changes in alertness and attention. Different impacts incorporate Parkinson's illness like signs and side effects, for example, inflexible muscles, moderate development and tremors.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 3: Care Practice and Awareness

Persons with dementia have multiple psychological feature deficits that embody every memory impairment, that affects the flexibleness to seek out new data or recall data antecedently learned, and one or extra of the next symptoms-aphasia, apraxia, agnosia, or government dysfunction-such that the psychological feature deficits negatively have an impression on social or activity functioning with a giant decline in previous skills. to boot, persons with dementia generally suffer from comorbid conditions that extra complicate care and impede best outcomes. Therefore, developing caregiving ways individuals with dementia is pressing, given this increasing prevalence and so the associated burden that dementia places not solely on the people, but on the caregivers, relations, and so the resources of the health care system. standard views relating geriatric nursing generally paint a picture of the care as being slow paced sure and fewer hard than acute care. However, care of the aged, and significantly those with dementia, is sometimes difficult, unpredictable, and unstable.

This session includes education and coaching of medical professionals, care and quality of life, Person focused care, psychological feature coaching, Support and coaching for casual and skilled careers, putt knowledge domain into apply, Non-pharmacological Interventions, practical foods, and art, music and life vogue.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 4: Ageing and Dementia

Half of people over age 50 have mild forgetfulness linked to age-associated memory impairment, although there are some normal age-related changes in memory and thinking, confusion and memory loss that interfere with your daily life are not part of the normal aging process. Other signs of ageing and dementia include, not being able to complete tasks independently, difficulty with naming items or close family members, forgetting the function of items, repeating questions, taking much longer to complete customary tasks, misplacing items frequently, not being able to retrace steps and getting lost.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 5: Dementia Nursing

Nursing of dementia patients need to understand them. Moreover, individuals with dementia regularly experience the evil impacts of comorbid conditions that additional befuddle psyche and square best outcomes. When things get challenging, nursing people with dementia, and their families: giving them one-to-one support, expert guidance and practical solutions.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 6: Recent Studies & Case Reports

Dementia may be a progressive, irreversible decline in noesis that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementedness has many etiologies of that Alzheimer’s sickness (AD) is that the most typical.

Drug development in AD is predicated on evolving pathophysiological theory. sickness modifying approaches embrace the targeting of amyloid process, aggregation of alphabetic character, endocrine signal, neuro-inflammation and neurochemical pathology, with efforts to date yielding abandoned hopes and current promise. reflective its dominance on the pathophysiological stage the amyloid cascade is central to several of the rising drug therapies.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 7: Alzheimer’s Disease

Alzheimer's disease is the most common cause of dementia among older adults that usually starts slowly and worsens over time. The most common early symptom is difficulty in remembering recent events short-term memory loss. By the final stage of Alzheimer’s, damage is widespread, and brain tissue gets shrunk significantly. As the disease advances, symptoms can include problems with language, mood swings, loss of motivation, not managing self-care, and behavioural issues. Gradually, bodily functions are lost, ultimately leading to death.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 8: Alzheimer’s Clinical Trials and Studies

Clinical trials square measure inquired regarding examinations junction rectifier in people to decide if medicines square measure protected and viable. While not clinical analysis and the help of human volunteers, there is no higher medications, no compensatory action and no cure for Alzheimer's ill.

Clinical trials square measure often alluded to as clinical examinations; the terms square measure of utilized reciprocally, however their square measure retiring contrasts between them. Clinical trials look at new intercessions or medications to avoid, acknowledge or treat infection. A clinical report is any variety of clinical analysis together with people, paying very little heed as to if it's Associate in Nursing an intercession. Clinical examinations will likewise take a goose at totally different components of care, for instance, enhancing personal satisfaction.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 9: Novel Therapeutic Targets and Mechanisms for Treatment

Alzheimer's illness could be a progressive neurodegenerative disease that's characterized histopathologically by the presence of plaques, principally composed of Abeta amyloid and the tangles, principally composed of hyper phosphorylated alphabetic character. To date, there's no treatment which will reverse the illness, and everyone this medical specialty is directed to address the symptoms of the illness. Here we tend to describe the efforts dedicated to attack the plaques and, in additional detail, the method of neurofibrillary degeneration, connected to the presence of the hyper phosphorylated tubule associated super molecule alphabetic character. we've known the various purported targets for medical specialty and the current data on them.

Treatment for Alzheimer's is coming into a brand new and exciting section, with many new medications starting clinical trials. several of those new therapies area unit supported our greatest current understanding of the pathologic process of Alzheimer's, and area unit designed to undertake to either slow or halt the progression of the illness. There are a unit many completely different theories underlying this effort, and these area unit in short reviewed. Therapies directed against some side of beta-amyloid formation, against neurofibrillary tangle formation and against the inflammatory response area unit all thought-about, as area unit the issues related to every space. it's nevertheless unclear that, if any of those approaches are undefeated, however the high level of activity in every of those 3 fields provides some hope that a good treatment for Alzheimer's is on the horizon.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 10: Amyloid Protein in Alzheimer’s and Dementia

The amyloid plaques and neurofibrillary tangles formation are thought to contribute to the degradation of the neurons (nerve cells) in the brain and the subsequent symptoms of Alzheimer's disease.

Amyloid Plaques: One of the hallmarks of Alzheimer's disease is the accumulation of amyloid plaques between nerve cells (neurons) in brain. Amyloid generally indicates protein fragments that the body produces normally. Beta amyloid is a protein fragment from an amyloid precursor protein (APP). In a healthy brain, these protein fragments are broken down and get eliminated. In Alzheimer’s, the fragments get accumulated to form hard &insoluble plaques.

Neurofibrillary Tangles: Neurofibrillary tangles are insoluble twisted fibers found inside the brain's cells, consisting primarily of a protein called tau, which forms structure called a microtubule. Transport of nutrients and other important substances from one part of the nerve cell to another done by help of microtubule. In Alzheimer's disease, the tau protein is abnormal and results in collapse of the microtubule structures.

This session includes Amyloid Protein and Alzheimer’s Disease, Amyloid beta metabolism in Alzheimer’s, Brain accumulation of toxic amyloid beta, Amyloid Plaques and Neurofibrillary Tangles, Amyloid Neuroimaging and biomarkers, Amyloidosis and Neurodegeneration, The amyloid hypothesis and potential treatments, Amyloid beta deposition, cognition and brain volume.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 11: Molecular Genetics and Biology of Dementia

Alzheimer’s disease and Frontotemporal Dementia are two basic common types of neurodegenerative dementias. Considerable progress has been made in our understanding of the genetics and molecular biology of dementia. This progress in genetic research is having a dramatic effect on our understanding of disease pathogenesis, by refining previous ideas and defining new primary disease mechanisms.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 12: Neurodegenerative Diseases

Neurodegenerative diseases incorporate wide selection of disorders, characterized by the progressive degeneration or death of nerve cells. It affects animal tissue and causes completely different psychological science manifestations furthermore. it's Associate in Nursing umbrella term for a variety of conditions that notably influence the neurons within the human brain.

Genetic and environmental factors are shown to play an important role within the development of neurodegenerative diseases. Age is one in every of the key risk factors that's common between every type of neurodegenerative unwellness because it progresses at older ages ordinarily.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 13: Psychiatry Mental Health Disorders

Psychiatric disorder is a mental illness which causes disturbs mood, thinking, and change behaviour. It may depend on your family, your life experiences, such as stress or a history of abuse, Biological factors such as chemical imbalances in the brain, traumatic brain injury, use of alcohol or recreational drugs, having a serious medical condition like cancer. It can be diagnosed by physical exam and possibly lab tests, if your provider thinks that other medical conditions could be causing your symptoms. Treatment depends on which mental disorder you have and how serious it is.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Track 14: Animal Models and Translational Medicine

Animal models for Alzheimer’s illness it's vital to trust the human makeup and what's being sculptural in terms of the animal makeup. The animal models of Alzheimer’s illness, supported the genetic science of the illness and the closely connected frontotemporal dementedness, replicate a minimum of a number of the pathology. Researchers are eminent at modeling terribly specific aspects of Alzheimer’s illness within the mouse (e.g., plaques, tangles). though these area unit incomplete models of the human illness, they need been well received within the field as doubtless relevant models to be used in drug discovery.

Patients with Alzheimer’s illness can show each amyloidopathy and tauopathy; but scientists usually focus, in a very theory approach, on one or the opposite in Associate in nursing animal model. A participant value-added that although the anatomy within the mouse is totally different than the human, mutant letter of the alphabet mice area unit comparatively sensible models in this they recapitulate tau-dependent neurodegeneration. This has crystal rectifier several corporations to specialize in antibodies that block tau-dependent neurodegeneration in these mouse models.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2021 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2021 USA | Dementia Conferences 2021 Europe | Dementia Conferences 2021 Asia | Brain Disorder Conferences

Market Analysis

Dementia is general term for memory misfortune and alternative intellectual capacities sufficiently real to intervene existence. This gathering can build info, offer help, facilitate learning and alter families and carers to go looking out relevant administrations for his or her idolized one and to create up the foremost ideal home condition to assist healing from this fascinating and decimating malady.

The global Alzheimer’s sickness (AD) market value $2.9 billion in 2016 is ready to achieve $14.8 Billon, rising at a Compound Annual rate of growth (CAGR) of seventeen.5%, across the 7 Million by 2026 consistent with world information, a recognized leader in providing business info and analytics Alzheimer's disease is that the commonest style of dementia. The proportions of these with totally different varieties of dementia are often dampened as follows:

Alzheimer's disease: sixty-two

Vascular dementia: Revolutionary Organization 17 November

Mixed dementia: 100%

Lewy-body dementia: four-dimensional

Fronto-temporal dementia: two

Parkinson's dementia: two

Other: 3%

According to United Nations agency 47.5 million folks have dementedness and each year 7.7 million new cases square measure showing. By 2030 total cases of dementia is projected to be 75.6 million and virtually triple by 2050 to one hundred thirty-five.5 million. Alzheimer’s sickness contributes 60-70 you look after cases in dementia and second commonest condition of dementedness is tube-shaped structure dementia that contributes 2 hundredth of cases everywhere the globe. Total calculable price of dementedness is 818 billion U.S.A. $ in 2018.

Past Conference Report

Dementia 2020

We are thankful to all our wonderful Speakers, Conference Attendees, Students and Associations for making Dementia 2020  Conference the best ever!

14th International Conference on Alzheimers Disease & Dementia was held on October 12-13, 2020; Webinar based on the theme “Advancements and Challenges in the Fields of Dementia Research". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Pediatrics, who made this event an outstanding success.

Conference Series LLC Ltd expresses its gratitude to all the participants who made this event grad success.

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Conference Series LLC Ltd offers its heart felt appreciation to keynote speakers, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interweaved with the organisation and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Dementia 2021, Conference Series LLC Ltd would like to announce the commencement of the “14th International Conference on Alzheimers Disease & Dementia” to be held in September 27-28, 2021 Dublin, Ireland. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Alzheimers Disease & Dementia.

Mark your calendars for the upcoming Conference; we are hoping to see you soon!

Let us meet again @ Dementia 2021

For More details visit: https://alzheimers-dementia.neuroconferences.com/


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 27-28, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journals of Alzheimers Disease and Parkinsonism Journal of Neurological Disorders Journal of Neurology and Neuroscience

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • 3x-Tg-Alzheimer?s Disease
  • Acetylcholinesterase
  • Advances In Lewy Body Dementia Research
  • Advances Of Research In Ageing And Dementia
  • Age-related Macular Degeneration
  • Ageing And Dementia
  • Alzheimer Disease And Cellular Mechanisms
  • Alzheimer's Illness
  • Alzheimer?s Clinical Trials And Studies
  • Alzheimer?s Clinical Trials And Studies
  • Alzheimer?s Disease
  • Alzheimer?s Disease
  • Alzheimer?s Disease Early Diagnosis And Symptoms
  • Alzheimer?s Disease Imaging
  • Alzheimer?s Sickness
  • Alzheimer?s Sickness
  • Alzheimer?s, Barrier And Transport
  • Amnestic Mild Cognitive Impairment
  • Amyloid
  • Amyloid Beta
  • Amyloid Neuroimaging And Biomarkers
  • Amyloid Plaques And Neurofibrillary Tangles
  • Amyloid Protein In Alzheimer?s And Dementia
  • Apolipoprotein E
  • Attention
  • Brain Ageing
  • Brain Sciences
  • Care And Quality Of Life
  • Care Practice And Awareness
  • Central Auditory Processing
  • Cerebrum Aggregation Of Poisonous Amyloid ? (A?)
  • Changes In Cerebral Cortical Microvasculature
  • Cistron Medical Care
  • Clinical Features Of Dementia
  • Clinical Motor Evaluation
  • Clinical Studies Of Alzheimer?s
  • Clinical Trials
  • Coaching Of Medical Professionals
  • Cognitive Dysfunction
  • Cognitive Reserve
  • Concentration
  • Deep Brain Stimulation
  • Dementia
  • Dementia Lewy Body
  • Dementia Lewy Body
  • Dementia Nursing
  • Dementia Nursing Care Plan
  • Dementia Physiotherapy
  • Disease Mechanisms
  • Drug-delivery Systems
  • Emotional Intelligence
  • ER Stress
  • Eremostachys Labiosiformis
  • Fractal Dimension
  • Frontotemporal Dementia
  • Genetic
  • Genetic Risk For Alzheimer?s
  • Geriatric Nursing
  • Geriatrics
  • Granulovacuolar Degeneration
  • Huntington?s Disease (HD)
  • Image Grading
  • Late-onset Alzheimer?s Disease
  • Lipofuscin
  • Logopenic Primary Progressive Aphasia
  • Melatonin
  • Mental Health
  • Microglia
  • Mild Cognitive Impairment
  • Mitochondrial Pathology
  • Molecular Genetics And Biology Of Dementia
  • Molecular Genetics Of Frontotemporal Dementia
  • Molecular Genetics Of Neurodegenerative Dementias
  • Motor Abnormalities In Dementia
  • Motor Neurone Diseases (MND)
  • Multimorbidity
  • Music Therapy In Dementia
  • Neuro-anatomical Changes In Ageing
  • Neurochemical Pathology
  • Neurocognitive Testing
  • Neurodegenerative Dementias
  • Neurodegenerative Diseases
  • Neuroendocrine Pharmacology
  • Neurofibrillary
  • Neurogranin
  • Neuron
  • Neuroprotection
  • Neuropsychology
  • Neurotransmitter
  • Neurotransmitter Abnormalities
  • Neurotransmitter-based Targets
  • Neurotrophic Factors
  • Non-pharmacological Interventions
  • Other Dementias
  • Parkinson?s Disease
  • Pathophysiology And Disease
  • PD-related Disorders
  • Peripheral Retina
  • Person Focused Care
  • Polyglutamine Diseases
  • Positron Emission Tomography
  • Posterior Cortical Atrophy
  • Primary Progressive Aphasia
  • Prion Disease
  • Psychiatric Symptoms
  • Psychiatry Mental Health Disorders
  • Psychometrics
  • Quality Of Life
  • Randomized Controlled Trials
  • Recent Studies & Case Reports
  • Resistance Exercise
  • Risk Factors Of Alzheimer?s
  • Salidroside
  • Social Engagement
  • Speech Processing
  • Speech Recognition
  • Spinocerebellar Ataxia (SCA)
  • Stroop Color-word Test
  • Super Molecule Aggregation
  • Synaptic Plasticity
  • Temporal Lobe
  • Therapeutic Interventions In Dementia
  • Therapeutic Targets And Mechanisms For Treatment
  • Treatments Of Alzheimer?s
  • Vascular Dementia
  • Vascular Density
  • Visuospatial Abilities
  • White Matter Hyperintensities